These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6420864)

  • 21. [Acquired haemophilia].
    Buczma A; Windyga J
    Pol Arch Med Wewn; 2007; 117(5-6):241-5. PubMed ID: 18030874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of patients with acquired inhibitors.
    Sallah S; Aledort L
    J Thromb Haemost; 2005 Mar; 3(3):595-7. PubMed ID: 15748261
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A.
    Eisert S; Mosler K; Laws HJ; Göbel U
    Thromb Haemost; 2005 Apr; 93(4):792-3. PubMed ID: 15841330
    [No Abstract]   [Full Text] [Related]  

  • 27. Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients.
    Mingot-Castellano ME; Moret A; de Cos C; García-Candel F; Garrido R; González-Porras JR; López-Fernández MF; Quintana L; Rodríguez-González R; Marco P
    Blood Coagul Fibrinolysis; 2019 Apr; 30(3):127-132. PubMed ID: 30958453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemphigus vulgaris associated with acquired hemophilia A due to factor VIII inhibitor.
    Ishikawa O; Tamura A; Ohnishi K; Miyachi Y
    Acta Derm Venereol; 1993 Jun; 73(3):229-30. PubMed ID: 8105629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acquired haemophilia A].
    Smejkal P; Buliková A; Chlupová G; Zavřelová J
    Vnitr Lek; 2012; 58(7-8):571-8. PubMed ID: 23067181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired hemophilia: a case report.
    Flisiński M; Windyga J; Stefańska E; Huszcza S; Donderski R; Manitius J
    Pol Arch Med Wewn; 2008 Apr; 118(4):228-33. PubMed ID: 18575423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab in the treatment of acquired factor VIII inhibitors.
    Onitilo AA; Skorupa A; Lal A; Ronish E; Mercier RJ; Islam R; Lazarchick J
    Thromb Haemost; 2006 Jul; 96(1):84-7. PubMed ID: 16807656
    [No Abstract]   [Full Text] [Related]  

  • 32. Acquired haemophilia in recipients of depot thioxanthenes.
    Stewart AJ; Manson LM; Dasani H; Beddall A; Collins P; Shima M; Ludlam CA
    Haemophilia; 2000 Nov; 6(6):709-12. PubMed ID: 11122403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune tolerance therapy in patients with acquired hemophilia.
    von Depka M
    Hematology; 2004 Aug; 9(4):245-57. PubMed ID: 15621732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS; Favaloro E; Koutts J
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
    Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
    Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case history of acquired haemophilia A].
    Cermáková Z; Hrdličková R; Blahutová S; Ligová A
    Vnitr Lek; 2013 Apr; 59(4):313-6. PubMed ID: 23711058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acquired autoantibodies directed against human factor VIIIc. Treatment of 2 hemorrhagic accidents with porcine factor VIIIc].
    Moreau P; Staikowsky F; Laneelle D; Dellile F; Simonin D; Schiffer C; Laurian Y
    Presse Med; 1993 Mar; 22(10):472-4, 479. PubMed ID: 8511068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Factor VIII inhibitors--their characteristics and clinical significance].
    Dmoszyńska A; Kniaź M; Sokołowska B
    Pol Arch Med Wewn; 1987 Dec; 78(6):333-40. PubMed ID: 3152083
    [No Abstract]   [Full Text] [Related]  

  • 39. The response to factor VIII infusion in inhibitor patients.
    Allain JP; Verroust F
    Prog Clin Biol Res; 1984; 150():99-108. PubMed ID: 6431445
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.